FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and can be applied for reduction of pathogenic properties of bacterial lipopolysaccharide (LPS). LPS suspension is exposed to linear-polarised light from red laser at wavelength 660 nm. Energy density is 4.0 J/ml. Exposure duration is 20 minutes.
EFFECT: method reduces lethal effect of bacterial LPS due to change of process of spontaneous LPS molecules structurization.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REDUCING LETHAL ACTION OF BACTERIAL LIPOPOLYSACCHARIDE in vitro | 2014 |
|
RU2544171C1 |
| MEDICATION INCREASING NON-SPECIFIC RESISTANCE OF ORGANISM TO BACTERIAL ENDOTOXINS | 2007 |
|
RU2351351C1 |
| METHOD FOR PRESSING THE GROWTH OF MYCOBACTERIUM TUBERCULOSIS POLYRESISTENT STAMPS IN EXPERIMENT | 2016 |
|
RU2628624C1 |
| ADJUVANT | 2020 |
|
RU2736933C1 |
| METHOD FOR PRODUCING LACTOFERRIN, LACTOFERRIN-CONTAINING FRACTION AND USING IT | 2010 |
|
RU2579661C2 |
| Shigella flexneri № 1605-8 BACTERIAL STRAIN, SEROTYPE 2a, DEPOSITED IN FEDERAL STATE INSTITUTION TARASEVICH STATE INSTITUTION OF STANDARTISATION AND CONTROL, NO 285, STABLE S-LIPOPOLYSACCHARIDE PRODUCER | 2009 |
|
RU2415921C1 |
| HOP EXTRACT | 2007 |
|
RU2344167C2 |
| AGENT FOR REDUCING SYSTEMIC PATHOLOGIC ENDOTOXINEMIA | 2014 |
|
RU2564918C1 |
| STRAIN OF RHODOBACTER CAPSULATUS PG - PRODUCER OF LIPOPOLYSSACHARIDE, ENDOTOXIN ANTAGONIST | 2008 |
|
RU2392309C1 |
| COMPOSITIONS CONTAINING FETAL HEMOGLOBIN AND BACTERIAL ENDOTOXIN AND OPTIONALLY, FETAL LIVER ADDITIVE | 2004 |
|
RU2366449C2 |
